Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics

2003/06/18 by Jordi Riba, Marta Valle, Gloria Urbano +3 · 7 citations
Neuroscience · Pharmacology, Toxicology and Pharmaceutics · Psychology · #Forensic Toxicology and Drug Analysis #Neurotransmitter Receptor Influence on Behavior #Psychedelics and Drug Studies

paper · doi:10.1124/jpet.103.049882

openalex publication_date 2003/06/18 · crossref created 2003/06/18 · crossref issued 2003/07/01 · crossref published 2003/07/01 · crossref published-print 2003/07/01 · crossref deposited 2025/02/19 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/09 · crossref indexed 2026/07/24

Citations

• Dose-Response Study of N,N-Dimethyltryptamine in Humans
• Dose-Response Study of N,N-Dimethyltryptamine in Humans

Cited by

• When the Endogenous Hallucinogenic Trace AmineN,N-Dimethyltryptamine Meets the Sigma-1 Receptor
• Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter
• Characterization of the synthesis of N,N‐dimethyltryptamine by reductive amination using gas chromatography ion trap mass spectrometry
• Neuropharmacology of N,N-dimethyltryptamine
• Serotonin and serotonin receptors in hallucinogen action
• Exposure to β-carbolines norharman and harman
• Dimethyltryptamine [wikipedia]